ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

ICU SeaStar Medical Holding Corporation

0.5083
-0.0059 (-1.15%)
Última actualización: 12:26:18
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
SeaStar Medical Holding Corporation ICU NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.0059 -1.15% 0.5083 12:26:18
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.5519 0.5001 0.5993 0.5142
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202407:30GLOBESeaStar Medical Announces $3.6 Million NIH Grant Award to..
17/4/202415:00GLOBESeaStar Medical Reports 2023 Financial Results and Provides..
11/4/202407:30GLOBESeaStar Medical to Present at the Noble Capital Markets’..
27/3/202407:30GLOBESeaStar Medical to Restate Financials, Sets Business Update..
12/3/202407:30GLOBESeaStar Medical Provides Updates on Enrollment of Adult..
11/3/202415:05GLOBESeaStar Medical-Sponsored Symposium Featuring Experts..
27/2/202407:30GLOBEManuscript Discussing the Benefit of SeaStar Medical’s..
22/2/202406:58GLOBENuwellis’ Distribution Partner, SeaStar Medical, Receives..
22/2/202406:53GLOBEFDA Grants Humanitarian Device Exemption Approval to SeaStar..
01/2/202407:30GLOBESeaStar Medical Granted Canadian Patent with Broad Claims..
26/1/202407:05GLOBESeaStar Medical Announces Pricing of $9.0 Million Registered..
11/1/202415:05GLOBESeaStar Medical Appoints David A. Green as Chief Financial..
09/1/202407:30GLOBESeaStar Medical Issued U.S. Patent with Broad Claims..
28/12/202307:30GLOBESeaStar Medical Updates Subject Enrollment in its Pivotal..
13/12/202307:30GLOBESeaStar Medical Forms Scientific Advisory Board of..
14/11/202315:04GLOBESeaStar Medical Reports Third Quarter 2023 Financial Results..
31/10/202307:00GLOBENuwellis’ Strategic Partner, SeaStar Medical, Receives FDA..
30/10/202307:00GLOBEFDA Issues Approvable Letter for SeaStar Medical’s Selective..
18/10/202307:30GLOBEFDA Grants SeaStar Medical’s Selective Cytopheretic Device..
05/10/202307:30GLOBESeaStar Medical to Present at the Dawson James Small Cap..
03/10/202315:05GLOBESeaStar Medical Provides Regulatory Update Regarding..
29/9/202307:30GLOBEFDA Grants Breakthrough Device Designation to SeaStar..
21/9/202308:35GLOBEDawson James Securities Announces October Date for 8th..
30/8/202315:35EDGAR2Form 8-K - Current report
29/8/202307:00GLOBECase Series of Three Critically Ill Children with Acute..
24/8/202316:15EDGAR2Form 8-K - Current report
22/8/202307:00GLOBESeaStar Medical to Hold Business Update Conference Call..
17/8/202316:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202316:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202316:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202315:45EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/8/202315:43EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/8/202315:41EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/8/202315:38EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/8/202305:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/8/202305:11EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/8/202305:10EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/8/202305:07EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/8/202305:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/8/202316:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202315:36EDGAR2Form PRE 14A - Other preliminary proxy statements
14/8/202315:35GLOBESeaStar Medical Reports Second Quarter 2023 Financial..
14/8/202315:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/8/202315:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/8/202315:08EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/8/202315:00EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
02/8/202315:19EDGAR2Form 8-K - Current report
31/7/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
20/7/202316:11EDGAR2Form S-1 - General form for registration of securities under..
05/7/202316:29EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]

Su Consulta Reciente

Delayed Upgrade Clock